Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/melanocortin receptor binding

被引：37
|
作者：
Arasasingham, PN
Fotsch, C
Ouyang, X
Norman, MH
Kelly, MG
Stark, KL
Karbon, B
Hale, C
Baumgartner, JW
Zambrano, M
Cheetham, J
Tamayo, NA
机构：
[1] Amgen Inc, Dept Small Molecule Drug Discovery, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 01期
关键词：
D O I：
10.1021/jm0255522
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin action.(1) In the hypothalamus, melanocortin peptide agonists act as satiety-inducing factors that mediate their action through the melanocortin-4 receptor (MC4R) whereas AGRP is an opposing orexigenic agent. Novel inhibitors of the AGRP/MC4 binding based on (piperazinylethyl)piperazines were prepared, and their structure-activity relationship was established.
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [21] Design, Synthesis, and Structure-Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists
    Laine, Dramane I.
    Wan, Zehong
    Yan, Hongxing
    Zhu, Chongjie
    Xie, Haibo
    Fu, Wei
    Busch-Petersen, Jakob
    Neipp, Christopher
    Davis, Roderick
    Widdowson, Katherine L.
    Blaney, Frank E.
    Foley, James
    Bacon, Alicia M.
    Webb, Edward F.
    Luttmann, Mark A.
    Burman, Miriam
    Sarau, Henry M.
    Salmon, Michael
    Palovich, Michael R.
    Belmonte, Kristen
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (16) : 5241 - 5252
  • [22] Current trends in the structure activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist
    Wilczynski, AM
    Joseph, CG
    Haskell-Luevano, C
    MEDICINAL RESEARCH REVIEWS, 2005, 25 (05) : 545 - 556
  • [23] Uncoupling the structure-activity relationship of β2 adrenergic receptor ligands from membrane binding
    Dickson, Callum
    Hornak, Viktor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [24] A2A adenosine receptor and its modulators:: Overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists
    Cristalli, G.
    Lambertucci, C.
    Marucci, G.
    Volpini, R.
    Dal Ben, D.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (15) : 1525 - 1552
  • [25] Himbacine derived thrombin receptor (PAR-1) antagonists: Structure-activity relationship of the lactone ring
    Xia, Yan
    Chackalamannil, Samuel
    Chan, Tze-Ming
    Czarniecki, Michael
    Doller, Dario
    Eagen, Keith
    Greenlee, William J.
    Tsai, Hsingan
    Wang, Yuguang
    Ahn, Ho-Sam
    Boykow, George C.
    McPhail, Andrew T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4969 - 4972
  • [26] Structure-activity study of kinin B1 receptor antagonists
    Regoli, D
    Neugebauer, W
    Gobeil, F
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R334 - R334
  • [27] THE STRUCTURE-ACTIVITY RELATIONSHIP OF INHIBITORS OF SEROTONIN UPTAKE AND RECEPTOR-BINDING
    HANSCH, C
    CALDWELL, J
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1991, 5 (05) : 441 - 453
  • [28] Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles
    Chu, L
    Hutchins, JE
    Weber, AE
    Lo, JL
    Yang, YT
    Cheng, K
    Smith, RG
    Fisher, MH
    Wyvratt, MJ
    Goulet, MT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) : 509 - 513
  • [29] STRUCTURE-ACTIVITY STUDY OF NEUROKININS - ANTAGONISTS FOR THE NEUROKININ-2 RECEPTOR
    DION, S
    ROUISSI, N
    NANTEL, F
    JUKIC, D
    RHALEB, NE
    TOUSIGNANT, C
    TELEMAQUE, S
    DRAPEAU, G
    REGOLI, D
    NALINE, E
    ADVENIER, C
    ROVERO, P
    MAGGI, CA
    PHARMACOLOGY, 1990, 41 (04) : 184 - 194
  • [30] STRUCTURE-ACTIVITY RELATIONSHIP OF NOVEL PENTAPEPTIDE NEUROPEPTIDE-Y RECEPTOR ANTAGONISTS IS CONSISTENT WITH A NONCONTINUOUS EPITOPE FOR LIGAND-RECEPTOR BINDING
    DANIELS, AJ
    MATTHEWS, JE
    VIVEROS, OH
    LEBAN, JJ
    CORY, M
    HEYER, D
    MOLECULAR PHARMACOLOGY, 1995, 48 (03) : 425 - 432
12345